ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP08

Should I Get the COVID-19 Vaccine With My RA? Using Evidence-Based Resources for Decision-Making

Aberdeen Allen, Colgate Palmolive, Parlin, NJ

Meeting: ACR Convergence 2021

Keywords: rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Title: Patient Perspectives Poster (PP01–PP09)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Patients with autoimmune rheumatic diseases have concerns about getting the COVID-19 vaccine. As vaccines began to receive emergency use authorization, individuals with conditions like rheumatoid arthritis (RA), looked for information to help make informed decisions. As a patient living with RA for 15 years, and on immunomodulating therapy for it, I was hesitant about getting the COVID-19 vaccine and needed to weigh the risks and benefits to feel confident getting a shot.

Intervention: People living with autoimmune diseases have nearly twice the risk of acquiring severe, vaccine-preventable infections. I was looking for reliable information about the new vaccine’s safety and efficacy, and information that would be specific to my needs and experience with RA. I knew that there wasn’t much information available on these vaccines that was specific to people with conditions like RA, so I was unsure of whether or when to get vaccinated. My questions were about whether to pause my RA medication, when to do so, and for how long. I wanted to know about possible side effects, like RA flare, and to learn if one of the three available vaccines was best suited for me. I searched online for resources to help me make a decision and gain confidence about my choice.

Given the rapidly changing information about COVID-19, I was anxious to know what was and wasn’t evidence-based at every step (Figure 1). In my search, I came across the COVID-19 Patient Support Program offered by the Global Healthy Living Foundation (GHLF). The program shared up-to-date reliable information about COVID-19 through webinars, articles, and a newsletter circulated approximately weekly. Part of keeping up with the rapidly changing informational landscape involved accessing an online collection of fact-checked articles for patients called “COVID-19 Vaccine Information for Immunocompromised Patients” curated by GHLF and informed by medical experts. I learned through an informational webinar organized by GHLF about the American College of Rheumatology (ACR) guidance on COVID-19 vaccination for patients with autoimmune rheumatic diseases that it is important to know what questions to ask, especially when the evidence is changing or incomplete. In addition, after reading a Patient Support Program article called 7 Questions to Ask Your Rheumatologist If You’re Nervous About Getting the COVID-19 Vaccine, I was able to bring questions to with my doctor to help me reach a decision. Ultimately, I decided to get the COVID-19 vaccine (Figure 1).

Maintenance: I continue to have ongoing discussions with my rheumatologist about my concerns despite being fully vaccinated. This means I must stay updated by seeking out information on what experts are learning about COVID-19 as new evidence emerges.

Quality of Life: Being part of an online community like GHLF/CreakyJoints allowed me to voice my concerns and anxieties and to easily find information to address them. This allowed for more meaningful conversations between me and my doctor and helped me make an important decision: whether to get the COVID-19 vaccine. Now that I am fully vaccinated, I feel safer. I am enjoying life outside and socializing after being home for more than a year.

Figure 1. My steps to arrive at an informed decision about the COVID_19 vaccine


Disclosures: A. Allen, None.

To cite this abstract in AMA style:

Allen A. Should I Get the COVID-19 Vaccine With My RA? Using Evidence-Based Resources for Decision-Making [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/should-i-get-the-covid-19-vaccine-with-my-ra-using-evidence-based-resources-for-decision-making/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/should-i-get-the-covid-19-vaccine-with-my-ra-using-evidence-based-resources-for-decision-making/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology